MG Motor India to boost ventilator production with MAX Ventilator


A close-up of the logo of MG Motor at the Auto Expo 2020 at Greater Noida on the outskirts of New Delhi (Photo by MONEY SHARMA/AFP via Getty Images)
A close-up of the logo of MG Motor at the Auto Expo 2020 at Greater Noida on the outskirts of New Delhi (Photo by MONEY SHARMA/AFP via Getty Images)

MG MOTOR INDIA has joined hands with Gujarat-based MAX Ventilator to increase the production of ventilators. Max Ventilator is among the top 25 ventilator brands in the world and caters primarily to the private hospitals.

This collaboration is focussed on assisting the overall production of ventilators by addressing specific areas of the supply chain, IT system and manufacturing processes.

Part of AB Industries, MAX has been manufacturing ventilators for the past 25 years.

With this partnership, the production capacity would be increased five times to 300 ventilators per month in Phase I which should be completed within next eight weeks, said MG Motor India.

In the second phase, the production capacity can be enhanced up to 1,000 ventilators per month, depending upon the demand, especially from the government hospitals to help meet the shortage of the life-saving medical devices in the country, a company statement said.

“At MG, we are committed to supporting our country’s fight against COVID-19 crisis. We understand that ventilators are the most critical requirement at this time, and we would do our best to enhance ventilator production,” said Rajeev Chaba, president & managing director, MG Motor India.

“The collaboration comes as a result of aligned core values of both organisations and is designed to work towards the common goal of serving the communities around where our operations are based.”

Ashok Patel, MD of A.B. Industries – MAX Ventilator, said: “As a manufacturing company of respiratory ventilators, this collaboration with MG Motor will help us to scale up the production with our teams working together hand in hand. Collaborations like these will guarantee that we meet the requirements to treat the rising COVID-19 cases in India.”